Cardiovascular risk factor modification with quotidian hemodialysis

Contributions to Nephrology

Volumn 145, Issue , 2004, Pages 55-62

  Nesrallah, Gihad E ^a,d   Chan, Christopher T ^b   Buoncristian, Umberto ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^d HUMBER RIVER REGIONAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; HUMAN; METHODOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; TIME;

CARDIOVASCULAR DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS;

EID: 16544393907     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000081667     Document Type: Article

References (35)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-S119.
2. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999;10:1606-1615.
3. Zoccali C, Mallamaci F, Tripepi G: Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 2003;S105-S110.
4. Chan CT: Nocturnal hemodialysis: An attempt to correct the 'unphysiology' of conventional intermittent renal replacement therapy. Clin Invest Med 2002;25:233-235.
5. Horl MP, Horl WH: Hemodialysis-associated hypertension: Pathophysiology and therapy. Am J Kidney Dis 2002;39:227-244.
6. Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M: Daily dialysis: Long-term clinical metabolic results. Kidney Int 1983;33:S137-S140.
7. Buoncristiani U, Fagugli R, Pinciaroli M, Kulurianu H, Ceravolo G, Bova C: Control of blood pressure with daily hemodialysis. J Am Soc Nephrol 1997;8:216A.
8. Woods JD, Port FK, Orzol S, Buoncristiani U, Young E, Wolfe RA, Held PJ: Clinical and biochemical correlates of starting 'daily' hemodialysis. Kidney Int 1999;55:2467-2476.
9. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U: Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001;38:371-376.
10. Kooistra MP, Vos J, Koomans HA, Vos PF: Daily home haemodialysis in the Netherlands: Effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998;13:2853-2860.
11. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay R: Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 2003;42:S13-S17.
12. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, Langos V, Uldall R: Nocturnal hemodialysis: Three-year experience. J Am Soc Nephrol 1998;9:859-868.
13. Ting G, Kjellstrand C, Freitas T, Carrie B, Zarghamee S: Long-term study of high-cormorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003;42:1020-1035.
14. Buoncristiani U, Fagugli R, Ciao G, Ciucci A, Carobi C, Quintaliani G, Pasini P: Left ventricular hypertrophy in daily dialysis. Miner Electrolyte Metab 1999;25:90-94.
15. Nesrallah G, Bergman A, Heidenheim AP, Leitch R, Lindsay RM: Short hours daily and slow nocturnal hemodialysis improve blood pressure control: Are the mechanisms the same? J Am Soc Nephrol 2001;12:273A.
16. Chan CT, Harvey PJ, Picton P, Pierratos A, Miller JA, Floras JS: Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 2003;42:925-931.
17. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995;5:2024-2031.
18. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 2000;11:912-916.
19. Chan C, Floras J, Miller J, Richardson R, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002;61:2235-2239.
20. Buoncristiani U, Fagugli RM, Pinciaroli MR, Kulurianu H, Ceravolo G, Bova C: Reversal of leftventricular hypertrophy in uremic patients by treatment with daily hemodialysis. Contrib Nephrol. Basel, Karger, 1996, vol 119, pp 152-156.
21. Chan C, Floras JS, Miller JA, Pierratos A: Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002;17:1518-1521.
22. Chan CT, Mardirossian S, Faratro R, Richardson RM: Improvement in lower-extremity peripheral arterial disease by nocturnal hemodialysis. Am J Kidney Dis 2003;41:225-229.
23. Kim SJ, Goldstein M, Szabo T, Pierratos A: Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis. Am J Kidney Dis 2003;41:E12.
24. Zoccali C, Mallamaci F, Tripepi G: Nocturnal hypoxemia: A neglected cardiovascular risk factor in end-stage renal disease? Blood Purif 2002;20:120-123.
25. Hanly PJ, Pierratos A: Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001;344:102-107.
26. Chan CT, Hanly P, Gabor J, Picton P, Pierratos A, Floras JS: Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 2004;65:661-665.
27. Suliman ME, Stenvinkel P, Barany P, Heimburger O, Anderstam B, Lindholm B: Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: Influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis 2003;41:S89-S95.
28. Van Guldener C, Stehouwer C: Homocysteine metabolism in renal disease. Clin Chem Lab Med 2003;41:1412-1417.
29. Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A: Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol 2002;13:265-268.
30. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 1998;31:607-617.
31. Mucsi I, Hercz G, Uldall R, et al.: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998;53:1399-1404.
32. Al-Hejaili F, Leitch R, Heidenheim AP, Clement L, Nesrallah G, Lindsay RM: Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2002;14:2322-2328.
33. Lindsay R, Al-Hejaili F, Nesrallah G, Leitch R, Clement L, Heidenheim A, Kortas C: Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 2003;42:S24-S29.
34. Chan CT, Harvey PJ, Pierratos A, Miller JA, Floras JS: Importance of phosphate control on time course of improvement in vascular responsiveness in end-stage renal disease patients converted to nocturnal hemodialysis (abstract). Hemodial Int 2004;8(1):91.
35. Floridi A, Buoncristiani U, Fagugli R, Cantelmi MG, Covarelli C: Daily hemodialysis effectively lowers hyperhomocysteinemia in uremic patients. J Am Soc Nephrol 1998;9:A1187.